ACE2 and COVID-19: Anti-S IgG levels were also significantly increased in anti-ACE2 IgM–positive COVID-19 patients compared with anti-ACE2 IgM–negative patients (median 0.55 vs. 0.14; P = 0.028; Mann-Whitney test; Supplemental Figure 5A, right panel).